Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Actuate Therapeutics (ACTU) Institutional Ownership

Actuate Therapeutics logo
$2.38 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$2.40 +0.02 (+1.05%)
As of 05/22/2026 06:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Actuate Therapeutics (NASDAQ:ACTU)

Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$11.72M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$341.34K
Get ACTU Insider Trade Alerts

Want to know when executives and insiders are buying or selling Actuate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ACTU Institutional Buying and Selling by Quarter

Actuate Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2026 Royal Bank of Canada22,225$61K0.0%-37.0%0.094%
5/16/2026 ABS Direct Equity Fund LLC50,000$137K0.1%+657.9%0.211%
2/18/2026 Bridgeway Capital Management LLC30,982$190K0.0%N/A0.133%
2/17/2026 Royal Bank of Canada35,263$215K0.0%+172.2%0.152%
2/16/2026 Barclays PLC14,946$91K0.0%+68.6%0.064%
2/13/2026 Charles Schwab Investment Management Inc.23,841$146K0.0%+61.5%0.103%
2/13/2026 State Street Corp56,290$344K0.0%+12.8%0.242%
2/13/2026 Voss Capital LP1,300,000$7.96M0.4%+45.0%5.594%
2/13/2026 Wells Fargo & Company MN20,146$123K0.0%+48.8%0.087%
2/12/2026 Jane Street Group LLC16,625$102K0.0%N/A0.072%
2/11/2026 Deutsche Bank AG9,309$57K0.0%+640.0%0.040%
2/11/2026 LPL Financial LLC12,965$79K0.0%-20.0%0.056%
2/10/2026 Sfmg LLC20,000$122K0.0%+17.6%0.086%
2/10/2026 Rock Creek Group LP21,759$133K0.0%N/A0.094%
2/9/2026 Geode Capital Management LLC207,744$1.27M0.0%+42.9%0.894%
2/9/2026 Texas Capital Bank Wealth Management Services Inc94,592$579K0.0%N/A0.407%
1/30/2026 ABS Direct Equity Fund LLC6,597$40K0.0%N/A0.028%
11/20/2025 Voss Capital LP896,278$6.00M0.3%+213.2%3.857%
11/17/2025 Bank of America Corp DE4,872$33K0.0%-68.1%0.021%
11/12/2025 BIOS Capital Management LP10,049,996$67.23M75.6%+0.9%43.244%
11/7/2025Vanguard Group Inc.316,010$2.11M0.0%+19.5%1.360%
11/3/2025 New York State Common Retirement Fund6,200$41K0.0%-64.0%0.027%
10/29/2025 Northwestern University6,488$43K0.1%-76.6%0.028%
8/15/2025 Bank of America Corp DE15,292$93K0.0%+61,068.0%0.075%
8/14/2025 Voss Capital LP286,140$1.75M0.1%+101.0%1.398%
8/13/2025 New York State Common Retirement Fund17,200$105K0.0%N/A0.084%
8/13/2025 Northwestern Mutual Wealth Management Co.18,518$113K0.0%+492.6%0.090%
8/12/2025 BIOS Capital Management LP9,965,079$60.89M83.9%+0.7%48.681%
8/12/2025 Sfmg LLC14,550$89K0.0%+32.3%0.071%
8/8/2025 Geode Capital Management LLC118,050$721K0.0%+252.5%0.577%
7/17/2025 Gleason Group Inc.19,028$116K0.0%N/A0.097%
6/27/2025 Goldman Sachs Group Inc.22,358$151K0.0%+98.7%0.114%
5/16/2025Goldman Sachs Group Inc.22,358$151K0.0%+98.7%0.114%
5/14/2025Voss Capital LP142,381$964K0.1%+157.7%0.729%
5/9/2025Chicago Partners Investment Group LLC10,365$70K0.0%N/A0.053%
5/9/2025Sfmg LLC11,000$74K0.0%N/A0.056%
5/2/2025Sigma Planning Corp23,675$160K0.0%+47.3%0.121%
2/17/2025OMERS ADMINISTRATION Corp10,583$84K0.0%N/A0.054%
2/14/2025Mercer Global Advisors Inc. ADV16,344$130K0.0%N/A0.084%
2/14/2025Voss Capital LP55,246$440K0.0%N/A0.283%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
2/13/2025Envestnet Asset Management Inc.10,465$83K0.0%N/A0.054%
2/10/2025BIOS Capital Management LP9,893,651$78.75M83.7%N/A50.659%
2/6/2025Freestone Capital Holdings LLC10,000$80K0.0%N/A0.051%
2/3/2025Sigma Planning Corp16,075$128K0.0%N/A0.082%
11/12/2024Northwestern University27,778$207K0.2%N/A0.142%
10/29/2024KG&L Capital Management LLC12,000$89K0.0%N/A0.061%


ACTU Institutional Ownership - Frequently Asked Questions

During the previous two years, 30 institutional investors and hedge funds held shares of Actuate Therapeutics. The most heavily invested institutionals were BIOS Capital Management LP ($67.23M), Voss Capital LP ($7.96M), Vanguard Group Inc. ($2.11M), Geode Capital Management LLC ($1.27M), Texas Capital Bank Wealth Management Services Inc ($579K), State Street Corp ($344K), and Bridgeway Capital Management LLC ($190K).Learn more on Actuate Therapeutics' institutional investors.

Of the 29 institutional investors that purchased Actuate Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($10.05M), Voss Capital LP ($1.30M), Geode Capital Management LLC ($146.89K), Texas Capital Bank Wealth Management Services Inc ($94.59K), Vanguard Group Inc. ($51.55K), ABS Direct Equity Fund LLC ($50K), and Bridgeway Capital Management LLC ($30.98K).

Institutional investors have bought a total of 1,869,420 shares in the last 24 months. This purchase volume represents approximately $11.72M in transactions.

The following institutional investors have sold Actuate Therapeutics stock in the last 24 months: Northwestern University ($21.29K), Royal Bank of Canada ($13.04K), New York State Common Retirement Fund ($11K), Bank of America Corp DE ($10.42K), and LPL Financial LLC ($3.25K).

Institutional investors have sold a total of 58,998 shares in the last 24 months. This volume of shares sold represents approximately $341.34K in transactions.



This page (NASDAQ:ACTU) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners